These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8881680)

  • 1. Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis.
    Goulden V; Goodfield MJ
    Br J Dermatol; 1996 Aug; 135(2):305-6. PubMed ID: 8881680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor.
    Jarrett P; Rademaker M; Havill J; Pullon H
    Clin Exp Dermatol; 1997 May; 22(3):146-7. PubMed ID: 9425696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic epidermal necrolysis treated with intravenous immunoglobulin and granulocyte colony-stimulating factor.
    Kalyoncu M; Cimsit G; Cakir M; Okten A
    Indian Pediatr; 2004 Apr; 41(4):392-5. PubMed ID: 15123870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factor in toxic epidermal necrolysis (TEN) and Chelsea & Westminster TEN management protocol [corrected].
    de Sica-Chapman A; Williams G; Soni N; Bunker CB
    Br J Dermatol; 2010 Apr; 162(4):860-5. PubMed ID: 19912214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematological abnormalities and the use of granulocyte-colony-stimulating factor in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ang CC; Tay YK
    Int J Dermatol; 2011 Dec; 50(12):1570-8. PubMed ID: 22098009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of granulocyte colony-stimulating factor in the treatment of toxic epidermal necrolysis--experience with 3 patients.
    Mahajan R; Kanwar AJ
    Skinmed; 2013; 11(5):269-71. PubMed ID: 24340465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic epidermal necrolysis in a patient with severe aplastic anemia treated with cyclosporin A and G-CSF.
    Robak E; Robak T; Góra-Tybor J; Chojnowski K; Strzelecka B; Waszczykowska E; Sysa-Jedrzejowska A
    J Med; 2001; 32(1-2):31-9. PubMed ID: 11321886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of toxic epidermal necrolysis/Stevens-Johnson syndrome overlap with human granulocyte colony stimulating factor: a case report.
    Pallesen KA; Robinson S; Toft P; Andersen KE
    Acta Derm Venereol; 2012 Mar; 92(2):212-3. PubMed ID: 22068367
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recombinant granulocyte colony-stimulating factor as a new effective treatment of neutropenia].
    Fasth A; Carlson G; Ridell B
    Lakartidningen; 1992 Mar; 89(10):776-80. PubMed ID: 1371816
    [No Abstract]   [Full Text] [Related]  

  • 10. [Granulocyte colony-stimulating factor in a patient with toxic neutropenia and acquired immunodeficiency syndrome].
    Alba D; Ripoll MM; Rodríguez MD; Molina F
    Med Clin (Barc); 1992 Jul; 99(6):235-6. PubMed ID: 1380622
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of granulocyte colony-stimulating factor in neutropenic children.
    Justo LF; Cedola A
    Pediatr Infect Dis J; 1994 Nov; 13(11):1024-5. PubMed ID: 7531319
    [No Abstract]   [Full Text] [Related]  

  • 12. Beneficial effect of granulocyte-colony stimulating factor in scleromyxoedema associated with severe idiopathic neutropenia.
    Cohen AM; Hodak E; David M; Mittelman M; Gal R; Stern R
    Br J Dermatol; 1996 Oct; 135(4):626-9. PubMed ID: 8915161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Suprathel dressing in a young infant with TEN.
    Pfurtscheller K; Zobel G; Roedl S; Trop M
    Pediatr Dermatol; 2008; 25(5):541-3. PubMed ID: 18950395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor: a new approach in the treatment of childhood neutropenia.
    Little FM; Pais RC; Winton E; Ragab AH
    J Med Assoc Ga; 1992 Aug; 81(8):437-41. PubMed ID: 1380973
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The dilemma of stimulating factors in the recovery from chemotherapeutic neutropenia].
    Borbollo Escoboza JR; González Avante M; Alvarado Ibarra M
    Rev Invest Clin; 1996; 48(4):328. PubMed ID: 8966397
    [No Abstract]   [Full Text] [Related]  

  • 18. [Continuous treatment with colony stimulating factors (G-CSF) for neutropenia associated with type Ib glycogenosis].
    de Diego Fernández P; García Fernández JR; Moreno Madrid F; Sánchez Forte M
    An Esp Pediatr; 2001 Sep; 55(3):282-4. PubMed ID: 11676908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe neutropenia after renal transplantation and its reversal with granulocyte colony-stimulating factor.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Dec; 26(6):3098-9. PubMed ID: 7527945
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxic epidermal necrolysis in a child. A case report and review of the literature.
    Chiossi M; Piccotti E; Tubino B; Nemelka O; Di Pietro P
    Pediatr Med Chir; 2007; 29(4):218-20. PubMed ID: 17715606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.